Venture
Click Therapeutics, Inc.
Latest Form D 2026-10-01- CIK 1623326
- State NY
- Other Health Care
- 10 Form D offerings since 2014-11-04
- Total sold
- $187M
- across 10 offerings
- Rounds
- 10
- Form D offerings since 2014-11-04
- Latest round
- $50M
- 2026-10-01 · 021-599560
- Investors
- 1
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2026-10-01 · $50M · new
- 2014-11-04$1.1M021-227641
- 2015-08-06$1.8M021-245227
- 2016-04-19$805K021-261652
- 2017-04-20$3.7M021-285200
- 2018-06-28$17.3M021-315648
- 2021-11-05$52.1M021-419990
- 2024-11-21$3M021-530115
- 2024-11-21$8.3M021-530121
- 2025-04-01$48.6M021-542641
- 2026-10-01$50M021-599560new
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($52.1M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-599560 | First filed2026-10-01 | Latest2026-10-01 | Sought$50M | Sold$50M | Investors1 | Exemptions506(b) |
| 021-542641 | First filed2025-04-01 | Latest2025-04-01 | Sought$48.6M | Sold$48.6M | Investors3 | Exemptions506(b) |
| 021-530121 | First filed2024-11-21 | Latest2024-11-21 | Sought$8.3M | Sold$8.3M | Investors2 | Exemptions506(b) |
| 021-530115 | First filed2024-11-21 | Latest2024-11-21 | Sought$3M | Sold$3M | Investors1 | Exemptions506(b) |
| 021-419990 | First filed2021-11-05 | Latest2021-11-05 | Sought$52.1M | Sold$52.1M | Investors9 | Exemptions506(b) |
| 021-315648 | First filed2018-06-28 | Latest2018-06-28 | Sought$19.3M | Sold$17.3M | Investors50 | Exemptions506(b) |
| 021-285200 | First filed2017-04-20 | Latest2017-04-20 | Sought$5M | Sold$3.7M | Investors11 | Exemptions506(b) |
| 021-261652 | First filed2016-04-19 | Latest2016-04-19 | Sought$1.5M | Sold$805K | Investors8 | Exemptions506(b) |
| 021-245227 | First filed2015-08-06 | Latest2015-08-06 | Sought$3M | Sold$1.8M | Investors18 | Exemptions506(b) |
| 021-227641 | First filed2014-11-04 | Latest2014-11-04 | Sought$3.1M | Sold$1.1M | Investors13 | Exemptions506(b) |
Who backs Click Therapeutics, Inc. — 1 inferred investor — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2026-10-01
| Name | Relationship | Clarification |
|---|---|---|
| David B. Klein | RelationshipExecutive Officer, Director | Clarification— |
| Randall Stanicky | RelationshipExecutive Officer | Clarification— |
| Cris De Luca | RelationshipDirector | Clarification— |
| Jeffrey Berkowitz | RelationshipDirector | Clarification— |
| Alex Zisson | RelationshipDirector | Clarification— |
| Maria Forero | RelationshipDirector | Clarification— |
| Muzammil Mansuri | RelationshipDirector | Clarification— |
| Lezrene Cunningham | RelationshipDirector | ClarificationMs. Cunningham served as a Director on the date that the board approved the Offering and on the Date of First Sale. She resigned prior to the date hereof. |
| David Friedman | RelationshipDirector | Clarification— |
| Anthony Costello | RelationshipDirector | Clarification— |
| Bruce Robertson | RelationshipDirector | ClarificationMr. Robertson was elected a Director after the Date of First Sale and resigned prior to the date hereof. |
| Douglas Langa | RelationshipDirector | ClarificationMr. Langa was elected a Director after the Date of First Sale. |
Sales compensation
Named in Item 12 of its Form D filings
| Recipient | CRD | Broker-dealer | Offerings |
|---|---|---|---|
| Emerson Equity LLC | CRD130032 | Broker-dealerJonathan Sadowsky · CRD 2911276 | Offerings1 |
| Marta Zylka | CRD5578030 | Broker-dealerMerriman Capital, Inc. · CRD 18296 | Offerings1 |
| Zvi Ben-Zvi | CRD2994766 | Broker-dealerMerriman Capital, Inc. · CRD 18296 | Offerings1 |
Facts
As its latest Form D states them
- Industry
- Other Health Care
- State
- New York (NY)
- Exemptions
- Rule 506(b)
- First filed
- 2014-11-04
- Latest filing
- 2026-10-01
Who backs Click Therapeutics, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗